Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Dec 2;87(12):1404-10.
doi: 10.1038/sj.bjc.6600616.

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers

B Brenner  1 , N Siris, E Rakowsky, E Fenig, A Sulkes, H Lurie
Affiliations

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers

B Brenner et al. Br J Cancer. .

Abstract

In spite of the apparent improvement in outcome in locally advanced breast cancer, the prognosis remains dismal in many patients. The aim of this study was to define prognostic subgroups within this heterogeneous entity. Between 1990 and 1999, 104 consecutive patients with locally advanced breast cancer were treated by a multimodality programme consisting of 4-6 courses of CAF induction chemotherapy followed by surgery, breast-conserving when feasible. In most cases, chemotherapy was then resumed, up to a total of eight courses, followed by locoregional radiation therapy. Patients with hormone receptor-positive tumours received tamoxifen (20 mg day(-1)) for 5 years. At a median follow-up of 57 months, the 5-year overall survival for the entire group and the disease-free survival for the 94 operated patients were 65% and 53%, respectively. Univariate analysis identified 10 prognostic factors of overall and disease-free survival, of which four retained significance on multivariate analysis: inflammatory breast cancer (P=0.0000, P=0.0004, respectively), baseline tumour markers (P=0.003 for both), post-chemotherapy number of involved nodes (P=0.003; P=0.017) and extracapsular spread (P=0.052; P=0.014). In conclusion, besides inflammatory features, baseline tumour markers and post-chemotherapy nodal status are strong predictors of outcome in locally advanced breast cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Disease-free survival (A) and overall survival (B) by presence of inflammatory breast cancer (IBC).
Figure 2
Figure 2
Disease-free survival (A) and overall survival (B) by baseline tumour markers.
Figure 3
Figure 3
Disease-free survival (A) and overall survival (B) by number of metastatic axillary lymph nodes.
Figure 4
Figure 4
Disease-free survival (A) and overall survival (B) by extracapsular nodal spread.
See this image and copyright information in PMC

References

    1. CheungKLGravesCRLRobertsonFJR2000Tumour marker measurements in the diagnosis and monitoring of breast cancer Cancer Treatment Rev 2691102 - PubMed
    1. CoxDR1972Regression models and life tables JR Stat Soc Ser B 34187220
    1. DeLenaMZucaliRViganottiGValagussaPBonadonnaG1978Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer Cancer Chemother 15359 - PubMed
    1. EORTC Breast Cancer Cooperative Group2000Clinical Research and Treatment in Breast Cancer Manual for Clinical Research and Treatment in Breast CancerProceedings of the 2nd European Breast Cancer Conference, 2000,Brussels, BelgiumSeptember 26–304th edition,pp107108
    1. FeinDAMendenhallNPMarshRDBlandKICopelandIIIEMMillionRR1994Results of multimodality therapy for inflammatory breast cancer: an analysis of clinical and treatment factors affecting outcome Am Surg 6022225 - PubMed

MeSH terms